![]()
|
|
||||||||
(Received for publication, November 29, 1995, and in revised form, March 11, 1996)
From The First Department of Internal Medicine, Yokohama City
University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama
236, Japan
Fibronectin has been shown to bind to integrin
Volume 271, Number 26,
Issue of June 28, 1996
pp. 15724-15728
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
IIb
3 Located in the C-terminal
Heparin-binding Domain of Human Plasma Fibronectin
IIb
3 in Arg-Gly-Asp
(RGD)-dependent and -independent manners. A recent study
has indicated that a 29-kDa dispase-digestive fragment from the
C-terminal heparin-binding domain of human plasma fibronectin (lacking
RGD sequence) inhibits binding of fibronectin to thrombin-stimulated
platelets and ADP-induced aggregation (Tanabe, J., Fujita, H.,
Iwamatsu, A., Mohri, H., and Ohkubo, T. (1993) J. Biol.
Chem. 268, 27143-27147). We provide here the evidence that a
peptide corresponding to residues from Ala1704 to
Glu1718 (designated F1) from this fragment inhibited
binding of 125I-labeled 29-kDa fragment of fibronectin to
thrombin-stimulated platelets and ADP-induced aggregation. The F1
peptide bound directly to
IIb
3 integrin
receptor. These results indicate that a novel binding site in the
C-terminal heparin-binding region of fibronectin is localized within
the residues from Ala1704 to Glu1718. Binding
of 125I-labeled 29-kDa fragment of fibronectin to
thrombin-stimulated platelets was not inhibited by RGDS peptide and the
12-residue peptide from the cell-binding domain of fibronectin,
suggesting that binding site in the C-terminal heparin-binding domain
may be different from those of RGDS and the 12-residue peptide. This
additional
IIb
3-binding domain(s) in
fibronectin may also play some role for prevention of thrombus
formation by direct interaction with
IIb
3.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Bossard, L. V. d. Berghe, H. Laurell, C. Castano, M. Cerutti, A.-C. Prats, and H. Prats Antiangiogenic Properties of Fibstatin, an Extracellular FGF-2-Binding Polypeptide Cancer Res., October 15, 2004; 64(20): 7507 - 7512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Boshuizen, J. W. A. Rossen, C. K. Sitaram, F. F. P. Kimenai, Y. Simons-Oosterhuis, C. Laffeber, H. A. Buller, and A. W. C. Einerhand Rotavirus Enterotoxin NSP4 Binds to the Extracellular Matrix Proteins Laminin-{beta}3 and Fibronectin J. Virol., September 15, 2004; 78(18): 10045 - 10053. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. WAGA, K. SUGIMOTO, H. TANAKA, T. ITO, T. NAKAHATA, T. TATEYAMA, Y. KAKIZAKI, and M. YOKOYAMA IgA Interaction with Carboxy-Terminal 43-kD Fragment of Fibronectin in IgA Nephropathy J. Am. Soc. Nephrol., February 1, 1999; 10(2): 256 - 263. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |